Products

StokeStox

AI-native

StokestoxTM

stokestox.ai Finance / Financial Data & Research

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$249/mo
Higher than 95% of peersNiche median $19/mo
Creators
Michael La Barbera
@stokestoxai· 20 followers
Launched
7mo ago
2026-04-16 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@stokestoxai
  • Launched on Product HuntLaunch

    AI analyzes your stock portfolio in 3 seconds.

    Apr 16 · 7mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-11-20

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Independent Professional
$249/mo
Firm & Branch Office
$6,999/yr (billed annually)

Trial: Start 14-Day Pilot · 2 paid tiers ($249–$6999) · Observed 2026-11-10 · Source page

Entry price $249/mo, Higher than 95% of peers; “Financial Data & Research” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2026-04-16

Key pages

Desktop & mobile archive
Home
stokestox.ai/ Snapshot 2026-11-10

Questions & evidence

How much does StokeStox cost?
Independent Professional: $249/mo; Firm & Branch Office: $6,999/yr (billed annually). Observed 2026-11-10. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does StokeStox get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is StokeStox and what platforms does it support?
StokeStox is catalogued under Financial Data & Research: StokestoxTM. Supported platforms: Web.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.